Supported in part by a National Institutes of Health One Health grant, the study also aims to advance translational research between human and veterinary medicine, given the lack of effective treatments for both.

Acute pancreatitis is a painful, life-threatening condition that affects an estimated 1.8 million dogs and accounts for more than 330,000 hospital admissions in humans each year in the United States.

A new clinical trial is now enrolling canine patients, offering hope for improving treatment.

Lamassu Pets, the veterinary division of Lamassu Biotech , and The Ohio State University College of Veterinary Medicine Blue Buffalo Veterinary Clinical Trials Office ( BBVCTO ) have begun testing a canine-specific application of RABI-767, a novel therapeutic targeting acute pancreatitis, a life-threatening condition that currently has no effective treatments in either human or…